Cioffi Melina, SVP of Regulatory Affairs at Aquestive Therapeutics ($AQST), made one open market sale of company shares in the last 365 days, totaling $105,623. Her most recent AQST insider sale occurred on March 10, 2026. With no open market purchases recorded, her activity ranks 9,485th among 11,678 insiders, well below the average sale amount of $8.6 million and 6.37 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | Cioffi Melina | SVP, Regulatory Affairs | A | Common Stock | 100000 | $0.00 | 300,178.0000 | 122,003,113 | 49.96% | 0.08% |
| March 10, 2026 | Aquestive Therapeutics, Inc. | $AQST | Cioffi Melina | SVP, Regulatory Affairs | S | Common Stock | 25311 | $4.17 | 274,867.0000 | 122,003,113 | 8.43% | 0.02% |
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | Cioffi Melina | SVP, Regulatory Affairs | A | Non-Qualified Stock Option (right to buy) | 75000 | $4.29 | 75,000.0000 | 122,003,113 | 9999.99% | 0.06% |
| Dec. 2, 2025 | Aquestive Therapeutics, Inc. | $AQST | Cioffi Melina | SVP, Regulatory Affairs | F | Common Stock | 2083 | $5.93 | 200,178.0000 | 122,003,113 | 1.03% | 0.00% |
| May 15, 2025 | Aquestive Therapeutics, Inc. | $AQST | Cioffi Melina | SVP, Regulatory Affairs | A | Common Stock | 20000 | $0.00 | 202,261.0000 | 98,871,369 | 10.97% | 0.02% |